New and Upcoming Treatments for Acne
At the 17th Annual ODAC Dermatology, Aesthetic & Surgical Conference held in Orlando, Florida, Dr. Linda Stein Gold, Director of Dermatology Clinical Research and Division Head of Dermatology for the Henry Ford Health System, lectured on new and future treatments for acne. She opened her lecture by describing the traditional view of lesion progression in acne vulgaris, where the microcomedone …
At the 17th Annual ODAC Dermatology, Aesthetic & Surgical Conference held in Orlando, Florida, Dr. Linda Stein Gold, Director of Dermatology Clinical Research and Division Head of Dermatology for the Henry Ford Health System, lectured on new and future treatments for acne. She opened her lecture by describing the traditional view of lesion progression in acne vulgaris, where the microcomedone … 
Hormonal acne is a prevalent and frustrating condition among many women. For those who are unable to control the disease with topical medications alone, spironolactone is often a useful systemic agent. However, its off-label use and potential risk of hyperkalemia have raised the question about serum potassium monitoring. We continue our Therapeutic Cheat Sheet series, with a closer look at spirono … 
I’ll never forget the stories that my patients told me at our monthly hidradenitis suppurativa support group meetings in the Bronx. From women who were too embarrassed to wear short sleeves to men in so much pain they could not sit down properly, all of them had been impacted profoundly by this disease. That is why I was so excited to cover this lecture at the 2020 ODAC Dermatology, Aesthetic a … 
This month’s edition of our Patient Buzz series includes articles on treating acne, situational cleansing, and aquagenic urticaria just to name a few.
Be prepared for your patients’ questions about acne and other dermatologic conditions by perusing this list of skin, hair and nail articles from the consumer press:
Allure: Pimple Popper’s acne prevention tips
Allure: Guide t … 
Masculinizing hormone therapy (MHT) represents a common therapeutic intervention for transgender men (female-to-male) and other gender diverse individuals. MHT typically involves the use of one of several forms of parenteral testosterone (e.g. gel, patch, intramuscular, pellet).1 The goal of MHT is to help develop masculine secondary sex characteristics and/or suppress feminine characteristics in … 